August 2022 JASN Highlights: Addressing CKD Progression and Hazards of Intradialytic Hypotension
0:00
8:54
Two highlighted clinical studies: the first addresses the effect of combining a SGLT2 inhibitor and a MRA on proteinuria; the second considers vascular reactivity as a risk factor for cerebral hypoxia when blood pressure falls during dialysis treatments.
Więcej odcinków z kanału "Journal of the American Society of Nephrology (JASN)"
Nie przegap odcinka z kanału “Journal of the American Society of Nephrology (JASN)”! Subskrybuj bezpłatnie w aplikacji GetPodcast.